A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis

被引：0
|
作者：
Hiroshi Tamura
Akihisa Takasaki
Yasuhiko Nakamura
Fumitaka Numa
Norihiro Sugino
机构：
[1] Yamaguchi University Graduate School of Medicine,Department of Obstetrics and Gynecology
[2] Saiseikai Shimonoseki General Hospital,Department of Obstetrics and Gynecology
[3] Yamaguchi Grand Medical Center,Department of Obstetrics and Gynecology
[4] Tokuyama Central Hospital,Department of Obstetrics and Gynecology
来源：
Journal of Ovarian Research | / 7卷
关键词：
Endometriosis; GnRH agonist; Cytokine; Oxidative stress; Melatonin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Improvement of ovarian function and fertility in patients with endometriosis after combination therapy with levonorgestrel-releasing intrauterine system plus gonadotropin-releasing hormone agonist
    Ti, Aijun
    Zhang, Ting
    Jia, Lili
    Chen, Mingli
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (06) : 1313 - 1319
  • [22] Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis
    Kang, Jia-li
    Wang, Xiao-xia
    Nie, Miao-ling
    Huang, Xiao-hui
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2010, 69 (02) : 73 - 77
  • [23] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis A Randomized Controlled Trial
    DiVasta, Amy D.
    Feldman, Henry A.
    Sadler Gallagher, Jenny
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (03) : 617 - 627
  • [24] Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility
    Wang, JH
    Zhou, FZ
    Dong, MY
    Wu, RJ
    Qian, YL
    FERTILITY AND STERILITY, 2006, 85 (04) : 1037 - 1044
  • [25] Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey, Eric S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (04) : 283 - 288
  • [26] Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
    Tehraninejad, Ensieh Sh.
    Nekoo, Elham Azimi
    Ezabadi, Zahra
    Rashidi, Batool H.
    Amirchaghmaghi, Elham
    Matroud, Elham Pour
    ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (06) : 945 - 949
  • [27] Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study
    Thi Ngoc Lan Vuong
    Manh Tuong Ho
    Tan Duc Ha
    Huy Tuan Phung
    Gia Bao Huynh
    Humaidan, Peter
    FERTILITY AND STERILITY, 2016, 105 (02) : 356 - 363
  • [28] EFFECT OF GONADOTROPIN-RELEASING-HORMONE AGONIST ON THE BONE-MINERAL DENSITY OF PATIENTS WITH ENDOMETRIOSIS
    UEMURA, T
    MOHRI, J
    OSADA, H
    SUZUKI, N
    KATAGIRI, N
    MINAGUCHI, H
    FERTILITY AND STERILITY, 1994, 62 (02) : 246 - 250
  • [29] Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis
    Meresman, GF
    Bilotas, M
    Buquet, RA
    Barañao, RI
    Sueldo, C
    Tesone, M
    FERTILITY AND STERILITY, 2003, 80 : 702 - 707
  • [30] In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis
    Wong, KHH
    Simon, JA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) : 44 - 49
12345